Clinical trials
Withdrawn Phase 2 Multiple Sclerosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 14 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of California, Los Angeles | 2 |
| Department of Medical Services Ministry of Public Health of Thailand | 1 |
| Hoffmann-La Roche | 1 |
| Louisiana State University Health Sciences Center in New Orleans | 1 |
| Loxo Oncology, Inc. | 1 |
| Novartis Pharmaceuticals | 1 |
| Stony Brook University | 1 |
| The Cleveland Clinic | 1 |
| University Hospital, Antwerp | 1 |
| University at Buffalo | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Sclerosis | 14 |
| Fatigue | 2 |
| Alzheimer Disease | 1 |
| Muscle Spasticity | 1 |
| Parkinson Disease | 1 |
Trials
Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.